Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5671 AL 5685

The enhanced Wnt/β-catenin pathway upregulation by sacubitril/valsartan via neprilysin inhibition compared to valsartan in the rotenone induced Parkinson's disease rat model

Elkhial RT, Awny MM, El-Sayed EK, Nofal S.

Neuropharmacology. 2026 Feb 1;283:110734. doi: 10.1016/j.neuropharm.2025.110734. Epub 2025 Oct 23.

Effects of a specific rehabilitation protocol on muscle mass and function in Parkinson's disease: a multicenter prospective study

de Sire A, Marotta N, Prestifilippo E, Curci C, Lippi L, Zito R, Pisani F, Invernizzi M, Ammendolia A, Mezian K.

Disabil Rehabil. 2026 Apr;48(7):2104-2119. doi: 10.1080/09638288.2025.2578987. Epub 2025 Oct 27.

The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control population

Gigante AF, Vitucci B, Velucci V, Pellicciari R, Modugno N, Pietracupa S, De Bartolo MI, Costanzo M, Terravecchia C, Mascia MM, Muroni A, Ercoli T, Solla P, Magrinelli F, Conte A, Fabbrini G, Nicoletti A, Tinazzi M, Berardelli A, Defazio G, Belvisi D.

J Parkinsons Dis. 2026 Feb;16(1):136-145. doi: 10.1177/1877718X251388058. Epub 2025 Oct 28.

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Papathoma E, Tsitsi P, Vijiaratnam N, Aquino C, Duma SR, Kovacs N, Okeng'o KL, Shukla AW, Bhidayasiri R, Mestre TA, Ferro AS, Espay AJ, Tosin MHS, Skorvanek M, Markaki I.

Mov Disord Clin Pract. 2026 May;13(5):1124-1146. doi: 10.1002/mdc3.70410. Epub 2025 Oct 29.

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases

Painous C, Fernández M, Cámara A, Alba-Arbalat S, Soto M, Brenlla C, Muñoz E, Pérez-Soriano A, Valldeoriola F, Martí MJ, Tolosa E, Garrido A, Sánchez-Gómez A, Maragall L, Camós-Carreras A, Tió M, Martín N, Basora M, Buongiorno M, Pont-Sunyer MC, Delgado T, Planas-Ballvé A, Caballol N, Ávila A, Vilas D, Jaumà S, Marco C, de Fàbregues O, Matos N, Mas A, Mas N, Aragonés JM, Bejr-Kasem H, Navarro-Otano J, Montori-Palacín E, Balasa M, Sarto J, Borrego-Écija S, Roldán P, Perissinotti A, Molina-Porcel L, Aldecoa I, Pérez-Montesino J, de Mena L, Naranjo L, Ruiz-García R, Compta Y.

Mov Disord. 2026 Feb;41(2):500-508. doi: 10.1002/mds.70086. Epub 2025 Oct 29.

Human Cyclophilins-An Emerging Class of Drug Targets

Jurkova K, Navratilova H, Musilek K, Benek O.

Med Res Rev. 2026 Mar;46(2):475-512. doi: 10.1002/med.70021. Epub 2025 Oct 29.

Unveiling Rosmarinic Acid: Understanding Its Broad Spectrum of Bioactivities

Leong KF, Chen Z, Coghi P.

Planta Med. 2026 Feb;92(2):84-111. doi: 10.1055/a-2727-3201. Epub 2025 Oct 29.

Cannabidiol and Parkinson's disease: Investigating receptor interactions and their therapeutic implications

Okrah EA, Allan C, Doblin MS, Annesley SJ.

Pharmacol Ther. 2026 Jan;277:108943. doi: 10.1016/j.pharmthera.2025.108943. Epub 2025 Oct 27.

Pathophysiological mechanisms linking osteoarthritis and neurodegenerative disease risk

Prasoon P, Nguyen KL, Fathi PA, Gupta S, Arnab S, Jones E, Meyyappan A, Stehle EJ, Bethea JR.

Osteoarthritis Cartilage. 2026 Feb;34(2):193-212. doi: 10.1016/j.joca.2025.10.009. Epub 2025 Oct 28.

α6 nicotinic acetylcholine receptors: A pharmacological challenge with untapped therapeutic promise

Zhang B, Mao K, Ma L, Chen Y, Ren M, Xiong Y, Zhangsun D, Dong S, Luo S, Gao B.

Eur J Med Chem. 2026 Jan 15;302(Pt 1):118300. doi: 10.1016/j.ejmech.2025.118300. Epub 2025 Oct 25.

Dual-Task Gait Cognitive-Motor Interference as a Marker of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta-Analysis

Msigwa SS, Hong S, Mkwambe MC, Marealle E, Zhang X, Wang JY.

Mov Disord Clin Pract. 2026 Apr;13(4):876-888. doi: 10.1002/mdc3.70409. Epub 2025 Nov 1.

Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review

Virameteekul S, Shin C, Hirczy SS, Sarva H, Paul SS, Maetzler W, Mirelman A, Schneider RB, Hausdorff JM, Vizcarra JA, Klucken J, Monje MHG, Mancini M, Bonato P, Nieuwboer A, Horak FB, Rochester L, Sanchez-Ferro A, Zatti C, Fabbri M, Mestre TA, Reilmann R, Espay AJ, Bloem BR, Pilotto A, Bhidayasiri R; MDS Technology Study Group.

Mov Disord. 2026 Jan;41(1):40-62. doi: 10.1002/mds.70097. Epub 2025 Nov 1.

Addressing sexual difficulties in Parkinson's disease

Oprea E.

Rev Neurol (Paris). 2026 Jan-Feb;182(1-2):1-9. doi: 10.1016/j.neurol.2025.10.004. Epub 2025 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias